Pulmonx Corp

Pulmonx Corp

  • Price (USD)65.86
  • Today's Change2.92 / 4.64%
  • Shares traded86.13k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jan 22 2021 21:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • LUNG:NSQ price moved over -5.74% to 59.33
  • LUNG:NSQ price falls below 15-day moving average to 59.33 at 09:30 GMT
  • LUNG:NSQ price falls below 15-day moving average to 61.54 at 09:48 GMT
  • LUNG:NSQ price rises above 15-day moving average to 62.06 at 09:42 GMT

Key statistics

On Friday, Pulmonx Corp (LUNG:NSQ) closed at 65.86, -5.21% below its 52-week high of 69.48, set on Dec 31, 2020.
52-week range
37.64Oct 01 202069.48Dec 31 2020
Markit short selling activity
Previous close62.94
Average volume135.99k
Shares outstanding35.67m
Free float23.13m
P/E (TTM)--
Market cap2.35bn USD
EPS (TTM)-0.8081
Data delayed at least 15 minutes, as of Jan 22 2021 21:00 GMT.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.